(20 Jan 2021) Canakinumab- causes rapid and long-lasting improvement in oxygenation levels
Efficacy of canakinumab in mild or severe COVID-19 pneumonia https://doi.org/10.1002/iid3.400 34 patients with mild or severe non intensive care unit (ICU) coronavirus disease 2019 (COVID-19) were enrolled: 17 patients treated with standard therapy and 17 patients treated with a subcutaneous… Continue reading "(20 Jan 2021) Canakinumab- causes rapid and long-lasting improvement in oxygenation levels"